Description

History/Background:
5-Amino-1MQ (5-Amino-1-methyliquinolin-2(1H)-one) is a small molecule compound that has garnered attention in the fields of pharmacology and metabolic research. It is primarily recognized for its potential role as an inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). NNMT is involved in the metabolism of nicotinamide (vitamin B3) and has been implicated in various metabolic processes, including energy expenditure and fat metabolism.

Research on 5-Amino-1MQ has been driven by its potential applications in obesity, metabolic disorders, and age-related decline. By inhibiting NNMT, 5-Amino-1MQ may enhance metabolic processes and improve energy balance, making it a subject of interest for those studying weight management and metabolic health.

Benefits:
The potential benefits of 5-Amino-1MQ include:

Weight Loss and Fat Reduction: By inhibiting NNMT, 5-Amino-1MQ may promote increased energy expenditure and fat oxidation, potentially aiding in weight loss and body composition improvement.
Metabolic Health Improvements: Research suggests that 5-Amino-1MQ may positively influence various metabolic parameters, including insulin sensitivity and lipid profiles.
Increased Energy Levels: By enhancing metabolic processes, 5-Amino-1MQ may help improve energy levels, which can contribute to overall vitality and physical performance.
Potential Anti-Aging Effects: Some studies suggest that the modulation of metabolic pathways through NNMT inhibition may have implications for age-related decline and longevity.
Neuroprotective Properties: Preliminary research indicates that 5-Amino-1MQ may have neuroprotective effects, although this area requires further investigation.

Recommended Dosage:
As 5-Amino-1MQ is primarily studied in research settings and is not widely approved for medical use, there are no standardized dosage recommendations. However, anecdotal reports and preliminary studies suggest the following common dosing regimens:

Administration: 5-Amino-1MQ is typically administered orally in capsule or tablet form in research contexts.
Common Dosage: Dosing in studies has varied, but typical dosages often range from 100 to 300 mg per day, depending on the specific study and the population being assessed.

Important Considerations:

Regulatory Status: 5-Amino-1MQ is not currently approved by the FDA or other regulatory agencies for general medical use. Its safety and efficacy have not been fully established through large-scale clinical trials.
Source and Purity: If individuals choose to use 5-Amino-1MQ, it is crucial to consider the source of the compound, as products may vary widely in terms of purity and quality. Many products are sold as research chemicals, which may not be regulated.
Side Effects: The safety profile of 5-Amino-1MQ is still being researched, and potential side effects are not fully documented. Users should be cautious and monitor for any adverse reactions.
Consultation with Healthcare Professionals: Individuals considering the use of 5-Amino-1MQ should consult with healthcare professionals for guidance, especially given its unregulated status and the potential risks involved.